Opaleye Management’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Opaleye Management's BLSM Position: Q3 2026 in Review
Opaleye Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 175,000 shares worth $3.26M. The stake represents 0.37% of the portfolio and ranks #43 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Opaleye Management held 175,000 shares of BlossomHill Therapeutics worth $3.26M as of Q3 2026.
- BlossomHill Therapeutics was a new Opaleye Management position in Q3 2026.
- BlossomHill Therapeutics made up 0.37% of Opaleye Management's portfolio in Q3 2026, its #43 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Opaleye Management's 13F filing for Q3 2026, filed 16 Nov 2026.